DK1663141T3 - Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin - Google Patents
Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolinInfo
- Publication number
- DK1663141T3 DK1663141T3 DK04740995T DK04740995T DK1663141T3 DK 1663141 T3 DK1663141 T3 DK 1663141T3 DK 04740995 T DK04740995 T DK 04740995T DK 04740995 T DK04740995 T DK 04740995T DK 1663141 T3 DK1663141 T3 DK 1663141T3
- Authority
- DK
- Denmark
- Prior art keywords
- xylometazoline
- solution containing
- aqueous pharmaceutical
- pharmaceutical solution
- oxymetazoline
- Prior art date
Links
- HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 title abstract 4
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001528 oxymetazoline Drugs 0.000 title abstract 2
- 229960000833 xylometazoline Drugs 0.000 title abstract 2
- 239000003186 pharmaceutical solution Substances 0.000 title 1
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 239000000337 buffer salt Substances 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 150000003751 zinc Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10337186A DE10337186A1 (de) | 2003-08-13 | 2003-08-13 | Wässrige Wirkstoff-Lösung |
| PCT/EP2004/007780 WO2005018601A1 (de) | 2003-08-13 | 2004-07-14 | Wässrige phramateuziche lösung enthaltend oxymetazolin und/oder xylometazolin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1663141T3 true DK1663141T3 (da) | 2007-07-30 |
Family
ID=34201503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04740995T DK1663141T3 (da) | 2003-08-13 | 2004-07-14 | Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060222718A1 (pt) |
| EP (1) | EP1663141B1 (pt) |
| JP (1) | JP4750703B2 (pt) |
| KR (1) | KR20060065677A (pt) |
| CN (1) | CN100531733C (pt) |
| AT (1) | ATE357212T1 (pt) |
| AU (1) | AU2004266443A1 (pt) |
| BR (1) | BRPI0413478A (pt) |
| CA (1) | CA2535533C (pt) |
| CY (1) | CY1107633T1 (pt) |
| DE (2) | DE10337186A1 (pt) |
| DK (1) | DK1663141T3 (pt) |
| ES (1) | ES2282871T3 (pt) |
| MX (1) | MXPA06001596A (pt) |
| PL (1) | PL1663141T3 (pt) |
| PT (1) | PT1663141E (pt) |
| RU (1) | RU2343918C2 (pt) |
| WO (1) | WO2005018601A1 (pt) |
| ZA (1) | ZA200602071B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005075735A (ja) * | 2003-08-28 | 2005-03-24 | Rohto Pharmaceut Co Ltd | オキシメタゾリン含有組成物 |
| DE102007052380A1 (de) † | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
| CN101576539B (zh) * | 2009-06-19 | 2012-05-23 | 广东省药品检验所 | 一种盐酸赛洛唑啉中杂质a的测定方法 |
| DE202012002792U1 (de) | 2011-12-30 | 2013-01-03 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die nasale Applikation mit verbesserter Stabilität |
| EP3108245B1 (en) | 2014-02-18 | 2020-07-22 | Robert I. Henkin | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
| US20170348230A1 (en) | 2014-12-24 | 2017-12-07 | Jadran-Galenski Laboratorij D.D | A nasal composition containing sea water as stability-improving excipient |
| WO2017198702A1 (en) * | 2016-05-17 | 2017-11-23 | Proponent Biotech Gmbh | Carboxylic acid for treating/preventing nasal congestion |
| DE202017104738U1 (de) | 2017-07-31 | 2018-08-01 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Zusammensetzung für die nasale Applikation |
| CN107362141B (zh) * | 2017-08-16 | 2018-06-05 | 深圳大佛药业股份有限公司 | 一种盐酸羟甲唑啉鼻喷雾剂及其制备方法 |
| US20210244710A1 (en) * | 2018-07-02 | 2021-08-12 | Kangping Xiao | Stable pharmaceutical formulations of oxymetazoline |
| US10799481B1 (en) * | 2019-05-06 | 2020-10-13 | Rvl Pharmaceuticals, Inc. | Compositions and methods for treating ocular disorders |
| EP4404916A1 (en) | 2021-09-22 | 2024-07-31 | JADRAN - GALENSKI LABORATORIJ d.d. | An improved pharmaceutical composition for nasal use, preparation, and use thereof |
| CN117982422B (zh) * | 2024-04-03 | 2024-07-26 | 深圳大佛药业股份有限公司 | 一种用于治疗鼻炎的喷雾剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478565A (en) * | 1990-03-27 | 1995-12-26 | Warner-Lambert Company | Treatment of sinus headache |
| DE19549421C2 (de) * | 1995-11-10 | 1999-11-18 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
| CA2311530C (en) * | 1998-01-30 | 2008-06-10 | Novartis Consumer Health S.A. | Nasal solutions |
| JPH11302184A (ja) * | 1998-04-21 | 1999-11-02 | Taisho Pharmaceut Co Ltd | 点鼻用組成物 |
| TR200103694T2 (tr) * | 1999-06-22 | 2002-04-22 | Boehringer Ingelheim International Gmbh | Sabit ksilometazolin ve oksimetazolin çözeltisi |
| AU2001291159A1 (en) * | 2000-09-20 | 2002-04-02 | Shahinian Jr., Lee | Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
-
2003
- 2003-08-13 DE DE10337186A patent/DE10337186A1/de not_active Withdrawn
-
2004
- 2004-07-14 ES ES04740995T patent/ES2282871T3/es not_active Expired - Lifetime
- 2004-07-14 BR BRPI0413478-8A patent/BRPI0413478A/pt not_active IP Right Cessation
- 2004-07-14 AT AT04740995T patent/ATE357212T1/de active
- 2004-07-14 CN CNB2004800227931A patent/CN100531733C/zh not_active Expired - Fee Related
- 2004-07-14 CA CA2535533A patent/CA2535533C/en not_active Expired - Fee Related
- 2004-07-14 JP JP2006522915A patent/JP4750703B2/ja not_active Expired - Fee Related
- 2004-07-14 PL PL04740995T patent/PL1663141T3/pl unknown
- 2004-07-14 RU RU2006107446/15A patent/RU2343918C2/ru not_active IP Right Cessation
- 2004-07-14 US US10/567,845 patent/US20060222718A1/en not_active Abandoned
- 2004-07-14 WO PCT/EP2004/007780 patent/WO2005018601A1/de active IP Right Grant
- 2004-07-14 KR KR1020067002872A patent/KR20060065677A/ko not_active Application Discontinuation
- 2004-07-14 DE DE502004003305T patent/DE502004003305D1/de not_active Expired - Lifetime
- 2004-07-14 DK DK04740995T patent/DK1663141T3/da active
- 2004-07-14 AU AU2004266443A patent/AU2004266443A1/en not_active Abandoned
- 2004-07-14 EP EP04740995A patent/EP1663141B1/de not_active Expired - Lifetime
- 2004-07-14 MX MXPA06001596A patent/MXPA06001596A/es active IP Right Grant
- 2004-07-14 PT PT04740995T patent/PT1663141E/pt unknown
-
2006
- 2006-03-10 ZA ZA200602071A patent/ZA200602071B/en unknown
-
2007
- 2007-05-21 CY CY20071100685T patent/CY1107633T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2343918C2 (ru) | 2009-01-20 |
| RU2006107446A (ru) | 2007-09-20 |
| DE502004003305D1 (de) | 2007-05-03 |
| DE10337186A1 (de) | 2005-03-17 |
| MXPA06001596A (es) | 2006-05-19 |
| US20060222718A1 (en) | 2006-10-05 |
| KR20060065677A (ko) | 2006-06-14 |
| JP2007501817A (ja) | 2007-02-01 |
| ES2282871T3 (es) | 2007-10-16 |
| JP4750703B2 (ja) | 2011-08-17 |
| AU2004266443A1 (en) | 2005-03-03 |
| PL1663141T3 (pl) | 2007-07-31 |
| CN100531733C (zh) | 2009-08-26 |
| PT1663141E (pt) | 2007-06-27 |
| CN1832726A (zh) | 2006-09-13 |
| EP1663141B1 (de) | 2007-03-21 |
| CA2535533C (en) | 2011-10-18 |
| CA2535533A1 (en) | 2005-03-03 |
| WO2005018601A1 (de) | 2005-03-03 |
| ATE357212T1 (de) | 2007-04-15 |
| CY1107633T1 (el) | 2013-03-13 |
| ZA200602071B (en) | 2007-05-30 |
| BRPI0413478A (pt) | 2006-10-17 |
| EP1663141A1 (de) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107633T1 (el) | Υδατικο φαρμακευτικο διαλυμα περιεχον οξυμεταζολινη και/ή ξυλομεταζολινη | |
| NO20054018L (no) | Intranasal formulering av rotigotin | |
| CY1106468T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| AR025001A1 (es) | Formulacion de sal comun y moxifloxacina | |
| EA200602092A1 (ru) | Способ и композиция для лечения ринита | |
| AR035266A1 (es) | Solucion desinfectante basada en hipoclorito sodico y procedimiento para su preparacion | |
| PT1556371E (pt) | Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes. | |
| GEP20084340B (en) | Pharmaceutical compositions comprising fentanyl for intranasal delivery | |
| UA113749C2 (xx) | Композиція для назального застосування з покращеною стабільністю | |
| EA200870546A1 (ru) | Стабильные водные суспензии | |
| CY1105105T1 (el) | Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων | |
| NO20070250L (no) | S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor | |
| EA201070194A1 (ru) | Стабильная жидкая фармацевтическая композиция на основе тразодона | |
| NO20055882L (no) | Farmasoytiske formuleringer omfattende amoksicillin og klavulanat | |
| FR2883702B1 (fr) | Concentre emulsifiable contenant du 2',4'-difluoro-2-(alpha, alpha-trifluoro-m-tolyloxy)-nicotinanilide et composition aqueuse obtenue par dilution du concentre | |
| NO20044769L (no) | Behandling av smerte med ifendropil | |
| NO20060743L (no) | Nasal farmasoytisk sammensetning av piribedil | |
| NO20050834L (no) | Ny indolinforbindelse og medisinsk anvendelse derav | |
| ATE531427T1 (de) | Bekämpfung von hi-virus infektionen mit durch hypochlorige säure oxidiertem menschlichem blutplasma | |
| SE0401942D0 (sv) | New antimicrobial peptide complexes | |
| ECSP003603A (es) | Formulacion de sal comun y moxifloxacina | |
| RU2007116719A (ru) | НОВОЕ ПРИМЕНЕНИЕ ДЛЯ α-СИМПАТОМИМЕТИКОВ, ИМЕЮЩИХ 2-ИМИДАЗОЛИНОВУЮ СТРУКТУРУ | |
| DE50310743D1 (de) | Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat | |
| RU2003117898A (ru) | Способ местного лечения деструктивных форм неспецифических заболеваний легких, плевритов и эмпием плевральной полости | |
| RU2006118790A (ru) | Способ лечения мальабсорбции |